fr

EN DE

fr

EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2023

Molecular pharmaceutics

Almeida ER

Modeling the Cellular Uptake of Functionalized Carbon Nanohorns Loaded with Cisplatin through a Breast Cancer Cell Membrane.

2023

International journal of public health

Pozet A

Quality of Life and Needs in Caregivers: Results From the Prospective Multicentric Open-Label Randomized Study of Informal Caregivers of Elderly Patients.

2023

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Kurtz JE

Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.

2023

Langenbeck's archives of surgery

Addeo P

Sequential Y liver radioembolization and portal vein embolization: an additional strategy to downstage liver tumors and to enhance liver hypertrophy before major hepatectomies.

2023

Oncogene

El Baba R

Polyploidy, EZH2 upregulation, and transformation in cytomegalovirus-infected human ovarian epithelial cells.

2023

World neurosurgery

Todeschi J

Second Cancer affecting the Central Nervous System: Systematic Literature Review Exploring the Link between Malignant Melanoma and Glioblastoma.

2023

Journal of the European Academy of Dermatology and Venereology : JEADV

Khelef K

Duration of treatment with cemiplimab in advanced cutaneous squamous cell carcinoma in complete response : Real-life study.

2023

European journal of cancer (Oxford, England : 1990)

Baudry E

Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study.

2023

Journal of neuroradiology = Journal de neuroradiologie

Alonso SM

Is non-contrast MRI sufficient to detect meningioma residue after surgery ?

2023

Immunological reviews

Ghiringhelli F

Using immunogenic cell death to improve anticancer efficacy of immune checkpoint inhibitors: From basic science to clinical application.